Armata Pharmaceuticals (ARMP) Earnings Date, Estimates & Call Transcripts → HUGE BUY ALERT: Move Fast, Musk... (From Stansberry Research) (Ad) Free ARMP Stock Alerts $2.92 -0.29 (-9.03%) (As of 05/14/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest Earnings SummaryLatest Earnings DateMay. 7EstimatedActual EPS (May. 7) -$0.69 Missed By -$0.41 Consensus EPS (May. 7) -$0.28 Get Armata Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for ARMP and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueARMP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ARMP Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchHUGE BUY ALERT: Move Fast, Musk...I recently traveled to Phoenix, Arizona...And based on what I saw out there, I'm prepared to put my reputation on the line. Since 2018, my investment recommendations have averaged 115% per year. But one investment I've just discovered could blow them all away.You won't believe what I saw in Phoenix. Armata Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20241($0.52)($0.52)($0.52)Q3 20241($0.47)($0.47)($0.47)Q4 20241($0.45)($0.45)($0.45)ARMP Earnings Date and InformationArmata Pharmaceuticals last issued its quarterly earnings results on May 7th, 2024. The reported ($0.69) earnings per share for the quarter, missing the consensus estimate of ($0.28) by $0.41. The firm earned $0.97 million during the quarter, compared to analysts' expectations of $1.20 million. Armata Pharmaceuticals has generated ($2.27) earnings per share over the last year (($2.27) diluted earnings per share). Earnings for Armata Pharmaceuticals are expected to grow in the coming year, from ($1.90) to ($1.30) per share. Read More Armata Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript5/7/2024Q1 2024($0.28)($0.69)($0.41)($0.69)$1.20 million$0.97 million3/21/2024Q4 2023-($0.55)($0.55)($0.55)$0.68 million$1.53 million11/14/2023Q3 2023($0.33)($0.31)+$0.02$0.24$0.90 million$1.23 million8/14/2023Q2 2023($0.35)($0.28)+$0.07($0.39)$1.50 million$0.98 million5/11/2023Q1 2023($0.29)($0.40)($0.11)($0.40)$1.50 million$0.80 million3/16/2023Q4 2022($0.25)($0.29)($0.04)($0.29)$1.34 million$1.05 million Get the Latest News and Ratings for ARMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Armata Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/9/2022Q3 2022($0.27)($0.24)+$0.03($0.24)$1.38 million$1.34 million8/11/2022Q2 2022($0.26)($0.26)-($0.26)$0.95 million$1.88 million5/12/2022Q1 2022($0.20)($0.30)($0.10)($0.30)$0.95 million$1.24 million 3/17/2022Q4 2021($0.25)($0.23)+$0.02($0.23)$0.83 million$0.99 million11/10/2021Q3 2021($0.26)($0.22)+$0.04($0.22)$1.02 million$1.25 million8/11/2021Q2 2021($0.21)($0.25)($0.04)($0.25)$0.82 million$1.17 million Armata Pharmaceuticals Earnings - Frequently Asked Questions When did Armata Pharmaceuticals announce their last quarterly earnings? Armata Pharmaceuticals (NYSEAMERICAN:ARMP) last announced its quarterly earning data on Tuesday, May 7, 2024. Learn more on ARMP's earnings history. Did Armata Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Armata Pharmaceuticals (NYSEAMERICAN:ARMP) missed the analysts' consensus estimate of ($0.28) by $0.41 with a reported earnings per share (EPS) of ($0.69). Learn more on analysts' earnings estimate vs. ARMP's actual earnings. How much revenue does Armata Pharmaceuticals generate each year? Armata Pharmaceuticals (NYSEAMERICAN:ARMP) has a recorded annual revenue of $4.53 million. How much profit does Armata Pharmaceuticals generate each year? Armata Pharmaceuticals (NYSEAMERICAN:ARMP) has a recorded net income of -$69.04 million. ARMP has generated -$2.27 earnings per share over the last four quarters. What is Armata Pharmaceuticals's EPS forecast for next year? Armata Pharmaceuticals's earnings are expected to grow from ($1.90) per share to ($1.30) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Xtant Medical Earnings Results Outlook Therapeutics Earnings Results Gritstone bio Earnings Results Passage Bio Earnings Results bluebird bio Earnings Results Curis Earnings Results Sangamo Therapeutics Earnings Results AlloVir Earnings Results CEL-SCI Earnings Results aTyr Pharma Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NYSEAMERICAN:ARMP) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsAmerica’s worst nightmare?Porter & CompanyInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperHow to Make 100X on the AI BoomInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Armata Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
